Platzer R, Küpfer A, Bircher J, Preisig R
Eur J Clin Invest. 1978 Aug;8(4):219-23. doi: 10.1111/j.1365-2362.1978.tb00856.x.
Polymorphic acetylation was investigated in twenty-seven patients with Gilbert's syndrome using the sulphadimidine test. Whereas the finding of 51% slow acetylators in seventy-eight control persons agreed well with the expected frequency in a continental European population, the prevalence of slow acetylators in Gilbert's syndrome was increased to 78% (P less than 0.03, Woolf's G-test). After oral administration of 14C-aminopyrine there was no significant difference between seventeen patients with Gilbert's syndrome and twenty-seven normal controls in total plasma clearance of aminopyrine (280 +/- SD 100 and 270 +/- 60 ml/min) and in the disappearance curve of 14CO2 in breath (0.23 +/- 0.04 and 0.22 +/- 0.03 h-1, respectively). Thus, whereas aminopyrine metabolism appears unaffected in the examined patients, the data documents a new association between slow acetylator status and Gilbert's syndrome.
采用磺胺二甲嘧啶试验对27例吉尔伯特综合征患者的多态性乙酰化进行了研究。在78名对照者中,51%为慢乙酰化者,这一结果与欧洲大陆人群的预期频率相符,而吉尔伯特综合征患者中慢乙酰化者的比例增至78%(P<0.03,伍尔夫G检验)。口服14C-氨基比林后,17例吉尔伯特综合征患者与27例正常对照者在氨基比林的总血浆清除率(分别为280±标准差100和270±60 ml/min)以及呼出气体中14CO2的消失曲线(分别为0.23±0.04和0.22±0.03 h-1)方面均无显著差异。因此,尽管在所检查的患者中氨基比林代谢似乎未受影响,但这些数据证明了慢乙酰化状态与吉尔伯特综合征之间存在一种新的关联。